-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-mobile-devices_research-protocol.pdf
July 12, 2017 - Mobile Health Technology for Diabetes
Evidence-based Practice Center Program
Evidence Product Protocol
Project Title: Mobile Health…
-
effectivehealthcare-admin.ahrq.gov/products/copd-anticholinergic-medicines/research
January 01, 2020 - The multiple propensity score for analysis of dose-response relationships in drug safety studies.
-
effectivehealthcare-admin.ahrq.gov/products/hypofractionated-radiation-therapy/protocol
December 01, 2024 - In case they are relevant, additional domains, such as dose-response association and strength of association
-
effectivehealthcare-admin.ahrq.gov/products/kidney-disease-medicine/research-protocol
December 01, 2019 - Nov 01, 2024
Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response
-
effectivehealthcare-admin.ahrq.gov/products/outcomes-nutrition/protocol
June 01, 2022 - The AHRQ Task Order Officer reviewed the EPC response to contract deliverables for adherence to contract
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-tests-prognostic/methods
December 01, 2019 - Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.
-
effectivehealthcare-admin.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - Recommendation
X Systematic review
□ Technical brief
□ Evidence map
□ Rapid review
□ Rapid response
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - Dose-
response
association
This association, either across or within
studies, refers to a pattern … Use one of three levels:
• Present: Dose-response pattern observed
• Not present: No dose-response … pattern
observed (dose-response relationship not
present)
• NA (not applicable or not tested)
-
effectivehealthcare-admin.ahrq.gov/products/home-based-care/research-protocol
December 01, 2019 - In response to comments and our subsequent discussions we have: a) specified that visits may be made
-
effectivehealthcare-admin.ahrq.gov/products/stroke-atrial-fibrillation/research-protocol
December 01, 2019 - Additional domains to be used when appropriate are: coherence, dose-response association, impact of plausible
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s58.pdf
October 01, 2007 - important research by Cooper et
al11 on medication effects on birth-defect rates, which prompted
a policy response
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
March 13, 2012 - intervals of effect estimates
Additionally, when appropriate, the studies will be evaluated for dose-response
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/urinary-incontinence-update_research-protocol.pdf
June 06, 2017 - metaregression analyses to evaluate study, patient, and
intervention features and to evaluate dose-response
-
effectivehealthcare-admin.ahrq.gov/products/urinary-incontinence-update/research-protocol
December 01, 2020 - metaregression analyses to evaluate study, patient, and intervention features and to evaluate dose-response
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stroke-atrial-fibrillation_research-protocol.pdf
January 30, 2012 - Additional domains to be used when appropriate are: coherence, dose-response
association, impact of
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
December 01, 2019 - intervention, an assessment of the overall health status of patients is important because it may influence response
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-213-lower-limb-protheses-evidence-summary.pdf
September 01, 2018 - scale), LCI 5 (LCI with a 5 point ordinal scale),
and LCI10 4 (10-item scale which combined two of the response
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Treatment response was defined as a decrease in abdominal pain
from baseline of 30% or more in mean … rifaximin group, 3%; placebo
group, 5%).35
In April 2015, Pimental and associates36 reported treatment-response
-
effectivehealthcare-admin.ahrq.gov/products/organization-cancer-care/protocol
November 01, 2022 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/phenylketonuria/research-protocol
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…